# Safety of the Combination of SH003 and Docetaxel in Patients With Solid Cancer

> **NCT04360317** · PHASE1 · UNKNOWN · sponsor: **Kyunghee University Medical Center** · enrollment: 9 (estimated)

## Conditions studied

- Solid Tumor

## Interventions

- **DRUG:** Combination of SH003 and Docetaxel

## Key facts

- **NCT ID:** NCT04360317
- **Lead sponsor:** Kyunghee University Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** UNKNOWN
- **Start date:** 2020-06
- **Primary completion:** 2021-05
- **Final completion:** 2021-08
- **Target enrollment:** 9 (ESTIMATED)
- **Last updated:** 2020-04-24


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04360317

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04360317, "Safety of the Combination of SH003 and Docetaxel in Patients With Solid Cancer". Retrieved via AI Analytics 2026-05-25 from https://api.ai-analytics.org/clinical/NCT04360317. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*